Panitumumab | Drug Guide - MedSchool
Sign up to start your free trial of MedSchool Premium!Get Started
 
Drug Guide
 
 
#
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W
Z
 

Panitumumab

Bookmark
  •  
    IV
    Panitumumab
    Vectibix 
    • Mechanism of Action
    • A monoclonal antibody directed against epidermal growth factor receptor (EGFR / HER1), which is involved in cell signalling and is overexpressed in certain cancers. Inhibition of EGFR signalling pathways results in cell cycle arrest.

Clinical Use

    • Indication
    • Metastatic colorectal cancer that is EGFR positive, RAS wild type
    • Contraindications
    • May not be used in the presence of RAS or BRAF mutations (must be wild type).
    • Adverse Effects
    • Acneiform rash
    • Nausea / vomiting / diarrhoea / constipation
    • Abdominal pain
    • Headache
    • Fatigue
    • Anorexia
    • Hypomagnesaemia
    • Elevated LFTs
    • Anaemia
 
Feedback